C S BIO CO., et al. v. COMERICA BANK

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 9 C S BIO CO., et al., Case No. 22-cv-05033-RS Plaintiffs, 11 v. ORDER CONTINUING HEARING AND REQUESTING FURTHER BRIEFING

COMERICA BANK,

13 Defendant.

15 The hearing set for December 4, 2025, is hereby continued to January 8, 2025, to permit further briefing, as specified below. Defendant Comerica Bank’s motion for summary judgment contends plaintiffs CS Bio Co. and CCS Management, LLC (collectively “CS”) lack evidence to show a triable issue of fact that they suffered damages caused by Comerica’s alleged misrepresentations. The order granting in part and denying in part the motion to dismiss the Second Amended Complaint found that CS had viable claims based on two basic alleged misrepresentations: (1) assurances Comerica allegedly gave on November 20, 2020, and again on November 23, 2020, that CS could and should pay its contractor’s October invoice in the amount of $738,000 without jeopardizing funding of…